期刊文献+

低频重复经颅磁刺激对帕金森病运动功能和情感障碍的疗效观察 被引量:22

Effects of low frequency repetitive transcranial magnetic stimulation on motor function and affective disorder in patients with Parkinson's disease
原文传递
导出
摘要 目的从运动功能、情感障碍方面观察低频重复经颅磁刺激(rTMS)对帕金森病(PD)患者的治疗作用。方法rTMS组用1HzrTMS技术治疗20例PD患者共15d。10例与rTMS组相匹配的PD患者接受假刺激治疗15d。rTMS、假刺激治疗前后观察统一PD评定量表(UPDRS)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)的变化。结果rTMS治疗后20例患者运动功能症状改善良好,UPDRS评分由治疗前的(38.45±17.33)分降至(30.95±17.00)分,降低19.51%,(t=6.780,P〈0.01),UPDRS各项评分下降;HAMD总分由治疗前的(12.15±7.62)分下降到治疗后的(8.75±7.31)分,降低27.98%,(t=5.101,P〈0.01),躯体化、睡眠障碍和阻滞的因子分低于治疗前;HAMA评分无明显改变(t=1.757,P〉0.05)。强直型患者症状改善更为明显。假刺激组治疗前后各项指标差异无统计学意义。结论1Hz rTMS可以改善运动功能和抑郁症状,对焦虑无明显作用。 Objective To investigate the therapeutic effects of low frequency repetitive transcranial magnetic stimulation (rTMS) on motor function and affective disorder in patients with Parkinson's disease (PD). Methods Twenty PD patients were performed by 1Hz rTMS therapy for 15 days and 10 matched patients were performed sham stimulation. Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA) and Unified Parkinson' s Disease Rating Scale (UPDRS) were assessed before and 15 days after rTMS treatment. Results After treatment with rTMS, the motor function was improved, and UPDRS total score and UPDRS-Ⅰ, UPDRS-Ⅱ , UPDRS-Ⅲ scores were decreased. UPDRS score was decreased from (38. 45±17.33) to (30.95± 17.00) (t=6.780,P〈0.01).At the same time, HAMD score was decreased from (12.15±7.62) to (8.75 ± 7.31 ) (t =5. 101, P〈 0.01 ). The scores of somatization, blockage and sleep disorders were lowered after treatment, but the HAMA score had no significant change(t= 1. 757,P〉0.05). The rigidity of PD patients was improved obviously. All indexes had no improvement in sham stimulation group. Conclusions Low frequency rTMS may improve motor dysfunction and affective disorder in PD patients .
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2009年第9期729-732,共4页 Chinese Journal of Geriatrics
基金 河北省科学技术研究与发展计划项目(07276101D-66)
关键词 帕金森病 运动障碍 情绪障碍 经颅磁刺激 Parkinson disease Movement disorders Mood disorder Transcranial magnetic stimulation
  • 相关文献

参考文献21

  • 1Liu LX, Chen WF, Xie JX, et al. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Neurosci Res, 2008, 60:156-161.
  • 2Faherty CJ, Raviie Shepherd K, Herasimtsehuk A, et al. Environmental enrichment in aduhhood eliminates neuronal death in experimental Parkinsonism. Brain Res Mol Brain Res, 2005, 134:170-179.
  • 3Braak H,Ghebremedhin E, Rub U, et al. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res, 2004,318:121-134.
  • 4McDonald WM, Richard IH, DeI.ong MR. Prevalence, etiology, and treatment of depression in Parkinsonps disease. Biol Psychiatry, 2003, 54 : 363-375.
  • 5Mayberg HS, Starkstein SE, Sadzot B, et al Selective hypometabolism in the inferior frontal lobe in depressed patient s with Parkinson's disease. Ann Neurol, 1990, 28:57-64.
  • 6Slaughter JR, Slaughter KA, Nichols D, et al. Prevalence, clinical manifestations, etiology and treatment of depression in Parkinson's disease. J Neuropsychiaty Clin Neurosci, 2001, 13 : 187-196.
  • 7陆菁菁,龙洁.帕金森病伴发抑郁症状的研究近况[J].中国神经精神疾病杂志,2003,29(2):152-155. 被引量:18
  • 8Soysal A,Sobe I, Atay T,et al. Effect of therapy on motor cortical excitability in Parkinson's disease. Can J Neurol Sci,2008 ,35: 166-72.
  • 9Lefaucheur JP. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson' s disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol, 2005,116 : 244-253.
  • 10Wassermann EM, Grafman J, Berry C, et al. Use and safety of a new repetitive transcranial magnetic stimulator. Electroenceph Clin Neurophysiol, 1996, 101:412-417.

二级参考文献55

  • 1张小乔,梅元武,刘传玉.经颅磁刺激对脑梗死大鼠皮质c-Fos和BDNF表达的影响[J].中华物理医学与康复杂志,2006,28(2):86-89. 被引量:15
  • 2Howells DW, Porritt M J, Wong JY, et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Exp Neurol, 2000,166 : 127-135.
  • 3Shults CW. Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors. Neurol Clin, 1992,10:567-593.
  • 4Smith MP, Fletcher-Turner A, Yurek DM et al. Calcitfiol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res, 2006,31:533-539.
  • 5Chauhan NB, Siegel GJ, Lee JM. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J Chem Neuroanat,2001,21:27%288.
  • 6Pascual-Leone A, Vails-Sole J, Brasil-Neto JP,et al. Akinesia in Parkinson's disease. Ⅱ. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology, 1994,44 : 892-898.
  • 7Helmich BC, Siebner HB, Bakker M. et al. Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease. J Neurol Sci,2006,248, :84-96.
  • 8Funamizu H, Ogiue-Ikeda M, Mukai H, et al. Acute repetitive transcranial magnetic stimulation reactivates dopaminergic system in lesion rats. Neurosci Lett,2005,383:77-81.
  • 9Muller MB, Toschi N, Kresse AE, et al. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptlde tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology, 2000,23:205-215.
  • 10Gerlach M, Riederer P, Przuntek H ,et al. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur J Pharmacol, 1991,208:273-286.

共引文献51

同被引文献268

引证文献22

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部